Pathogenic human monoclonal antibody against desmoglein 3

Clin Immunol. 2006 Jul;120(1):68-75. doi: 10.1016/j.clim.2006.03.006. Epub 2006 Apr 25.

Abstract

Pemphigus vulgaris (PV) is a potentially fatal autoimmune mucocutaneous disease associated with production of IgG autoantibodies to desmoglein 3 (Dsg3), a 130-kDa epidermal cadherin protein. The binding of pathogenic antibody to Dsg3 on epidermal keratinocytes leads to loss of intercellular adhesion and results in intraepithelial blister formation. Here, we describe a human monoclonal antibody, PVMAB786, a Dsg3-specific IgG4 antibody, from an untreated patient with active PV. The antibody reacts with a 130-kDa protein on keratinocyte cell surfaces and recombinant Dsg3 protein, but not desmoglein 1 protein. PVMAB786 induces acantholysis in normal human skin and mucous membranes and induces a clinical and histological profile similar to human PV when injected into neonatal mice. PVMAB786 will be a valuable tool in identifying the role of Dsg3 in epithelial cell adherence and acantholysis, mechanisms of Dsg3 processing/presentation and V gene and isotype usage in PV pathogenesis.

MeSH terms

  • Acantholysis / immunology
  • Animals
  • Animals, Newborn
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use
  • Blotting, Western
  • Desmoglein 3 / immunology*
  • Epitope Mapping
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Immunoglobulin G / immunology*
  • Immunoglobulin G / therapeutic use
  • Immunohistochemistry
  • Immunotherapy / methods*
  • Intradermal Tests
  • Keratinocytes
  • Mice
  • Mice, Inbred BALB C
  • Pemphigus / immunology*
  • Pemphigus / therapy

Substances

  • Antibodies, Monoclonal
  • DSG3 protein, human
  • Desmoglein 3
  • Immunoglobulin G